معرفی
Yi-Ling Chen, DPhil, is a Career Development Fellow at the Nuffield Department of Medicine, University of Oxford, where she leads the Chen Group dedicated to lipid-mediated T cell immunity research.
Research Focus: Her work centers on Immunology and T cell Biology, specifically investigating lipid-reactive T cells in immune regulation, tissue homeostasis, and microbial defense. She employs high-dimensional proteotranscriptomics, T cell clonality analysis, and human immune organoid approaches to uncover molecular mechanisms for inflammatory and infectious disease interventions. Key interests include:
- Lipid antigen presentation via CD1 molecules
- T cell responses in psoriasis and skin inflammation
- Host-pathogen interactions with Group A Streptococcus and Staphylococcus aureus
- Translational applications for immune-mediated conditions
Publication Trends: Analysis of her 15 most recent publications (2020-2024) reveals consistent focus on CD1-mediated lipid antigen presentation across infectious diseases (dengue, COVID-19, bacterial infections) and inflammatory conditions (psoriasis). Her work bridges molecular immunology with clinical applications, featuring in journals like Nature Immunology, Cell, and Science Immunology, with emphasis on therapeutic target discovery.
Laboratory: The Chen Group operates within Oxford's Nuffield Department of Medicine, utilizing advanced immunological techniques to study T cell immunity in human disease contexts.
